Amid the backdrop of increasing US interest rates in August, fund managers proceeded with caution, prioritizing large-cap stocks that offered favorable valuations coupled with safety margins. Their approach in mid and small-cap investments was selective, choosing firms like LIC, Coal India, and notable pharmaceutical entities. There was also a surge in funding for NBFCs and research organizations in this period.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.